Medicines and Poisons Amendment Regulations (No. 3) 2024 (WA)

Western Australia

Medicines and Poisons Act 2014

Medicines and Poisons Amendment Regulations (No. 3) 2024

Western Australia

Medicines and Poisons Amendment Regulations (No. 3) 2024 Contents Medicines and Poisons Act 2014

Medicines and Poisons Act 2014

Medicines and Poisons Amendment Regulations (No. 3) 2024

Made by the Governor in Executive Council.

1.Citation

These regulations are the Medicines and Poisons Amendment Regulations (No. 3) 2024.

2.Commencement

These regulations come into operation as follows —

• (a)

  regulations 1 and 2 — on the day on which these regulations are published on the WA legislation website;

• (b)

  the rest of the regulations — on the day after that day.

3.Regulations amended

These regulations amend the Medicines and Poisons Regulations 2016.

4.Regulation 6 amended

In regulation 6 delete “exempt substance,” and insert:

exempt substance or nicotine,

5.Regulation 6A inserted

After regulation 6 insert:

6A. Classification of nicotine as poison (s. 4)

• (1)

  In this regulation —

included in the Register has the meaning given in the Therapeutic Goods Act 1989 (Commonwealth) section 3;

oromucosal administration means oromucosal use as defined in the current Poisons Standard section 6;

therapeutic use has the meaning given in the current Poisons Standard section 6;

transdermal administration means transdermal use as defined in the current Poisons Standard section 6.

• (2)

  Each substance described in an item in the Table is classified as a poison included in the Schedule specified in that item.

Table

Item	Schedule	Description of substance
1.	Schedule 4	NICOTINE in preparations for human use except: (a) in preparations for oromucosal or transdermal administration for human therapeutic use when included in the Register as an aid in withdrawal either from tobacco smoking or nicotine vaping; or (b) in tobacco prepared and packed for smoking.
2.	Schedule 7	NICOTINE except: (a) when included in Schedule 4; or (b) in preparations for oromucosal or transdermal administration for human therapeutic use when included in the Register as an aid in withdrawal either from tobacco smoking or nicotine vaping; or (c) in tobacco prepared and packed for smoking.

N. HAGLEY, Clerk of the Executive Council